FDA Approves HPV Drug Cervarix for Cervical Cancer Prevention in Girls
Links shared publicly online about this topic
Cervarix approved for prevention of HPV-associated cervical cancer - MPR
empr.com — “The FDA has approved Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant, from GlaxoSmithKline) for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and women 10"25 years of age.” View full resource at empr.com
Most Recently Shared on October 16, 2009 at 8:55 pm By:
MPR News: Cervarix approved for prevention of HPV-associated cervical cancer: The FDA has approved Cerv.. http://bit.ly/WF8uF
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine
drugs.com — “Cervarix (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is used for prevention of cervical cancer. Includes Cervarix side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 16, 2009 at 10:45 pm By:
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine - http://bit.ly/2Y6rH0
FDA Approves New Vaccine for Prevention of Cervical Cancer
fda.gov — “The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.” View full resource at fda.gov
Most Recently Shared on October 19, 2009 at 4:49 pm By:
FDA Approves Cervarix Vaccine for Prevention of Cervical Cancer: http://bit.ly/3aQ67b
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine | Reuters
reuters.com — “PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX [Human papillomavirus bivalent (types” View full resource at reuters.com
Most Recently Shared on October 16, 2009 at 4:16 pm By:
RT @Apfeiffer: RT @cancercures: FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine http://bit.ly/3PBG9D
FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent [Updated] | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “The food and drug administration today approved cervarix, the vaccine against human papilloma virus (hpv) manufactured by glaxosmithkline, for use in girls and young women ages 10 to 25. an fda adivsory panel recommended approval of the vaccine on sept....” View full resource at latimesblogs.latimes.com
Most Recently Shared on October 16, 2009 at 4:10 pm By:
FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent http://bit.ly/3NhY9x
Human Papillomavirus (HPV) Vaccines - National Cancer Institute
cancer.gov — “A fact sheet about human papillomavirus (HPV) vaccines for the prevention of infection with certain types of HPV, which is the major cause of cervical cancer.” View full resource at cancer.gov
Most Recently Shared on December 6, 2010 at 5:38 pm By:
RT @teamoncology: RT @NCIprevention: abt 6 million new HPV cases in US/yr. Get vaccinated 2 skip cervical, oral cancers http://bit.ly/ezCasi
FDA backs new cervical cancer vaccine Cervarix - Sexual health- msnbc.com
msnbc.msn.com — “Federal health officials favor approving GlaxoSmithKline's long-delayed vaccine Cervarix to prevent the leading cause of cervical cancer in U.S. women.” View full resource at msnbc.msn.com
Most Recently Shared on September 9, 2009 at 6:42 pm By:
FDA backs new cervical cancer vaccine Cervarix http://bit.ly/VTzE3
FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys
fda.gov — “The U.S. Food and Drug Administration today approved use of the vaccine Gardasil for the prevention of genital warts (condyloma acuminata) due to human papillomavirus (HPV) types 6 and 11 in boys and men, ages 9 through 26.” View full resource at fda.gov
Most Recently Shared on October 16, 2009 at 9:35 pm By:
FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys: http://bit.ly/1dyyaf
UPDATE 1-US OKs Merck shot to prevent male genital warts | Reuters
reuters.com — “* Gardasil cleared for males aged 9 to 26 * Shot already sold for women to fight cervical cancer * Merck shares down 5 cents LOS ANGELES, Oct 16 (Reuters) - Merck & Co won U.S. approval” View full resource at reuters.com
Most Recently Shared on October 17, 2009 at 12:45 am By:
RT: @hrana News: FDA approves Gardasil (HPV vaccine) for use in male genital wart prevention http://bit.ly/tQDyy
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Gannett Healthcare
Nursing Spectrum, NurseWeek and www.Nurse.com
Advertisement

